Radiopharm Theranostics Ltd 6-K, filed Dec 4, 2025
Radiopharm Theranostics Ltd (RADX)
About this 6-K
Radiopharm Theranostics Ltd filed this 6-K on December 4, 2025.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the Month of December 2025
Commission File Number: 001-41621
RADIOPHARM THERANOSTICS LIMITED
(Name of Registrant)
Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-
RADIOPHARM THERANOSTICS LIMITED
EXPLANATORY NOTE
Radiopharm Theranostics Limited (the “Company”) published an announcement (the “Public Notice”) to the Australian Securities Exchange on December 3, 2025 titled:
“Results of Meeting”
A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.
This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
1
EXHIBITS
| Exhibit Number |
Description | |
| 99.1 | Results of Meeting |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| RADIOPHARM THERANOSTICS LIMITED | ||
| Date: December 3, 2025 | By: | /s/ Phillip Hains |
| Phillip Hains | ||
| Company Secretary | ||
3
Exhibit 99.1
ASX ANNOUNCEMENT |
 |
Results of General Meeting
Sydney, Australia – Wednesday, 3 December 2025 – Radiopharm Theranostics Limited (ASX: RAD; Nasdaq: RADX) advises that all resolutions considered at the General Meeting held today were carried by poll.
In accordance with ASX Listing Rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, details of the proxies received and votes cast in respect of each resolution are attached.
Phillip Hains
Joint Company Secretary
Radiopharm Theranostics Limited
Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia
ABN: 57 647 877 889
| Disclosure of Proxy Votes |  |
| Radiopharm Theranostics Limited Extraordinary General Meeting Wednesday, 03 December 2025 |
GPO Box 5193, Sydney, NSW
2001 P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world) F +61 (0)2 8583 3040 E hello@automic.com.au ABN 27 152 260 814 |
In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting.
| Proxy Votes | Poll Results (if applicable) |
Results | ||||||||
| Resolution | Decided
by Show of Hands (S) or Poll (P) |
Total Number of Proxy Votes exercisable by proxies validly appointed |
FOR | AGAINST | ABSTAIN | PROXY’S DISCRETION |
FOR | AGAINST | ABSTAIN | OUTCOME |
| 1 Ratification of prior issue of First Tranche Placement Shares to Placement Participants | P | 310,229,670 | 297,621,056 95.94% | 10,828,904 3.49% | 674,119 | 1,779,710 0.57% | 585,859,279 98.19% | 10,828,904 1.81% | 674,119 | Carried |
| 2 Approval to issue Second Tranche Placement Shares | P | 310,191,235 | 297,822,621 96.01% | 10,588,904 3.41% | 762,554 | 1,779,710 0.57% | 303,102,331 96.62% | 10,588,904 3.38% | 283,721,067 | Carried |
| 3 Approval to issue Placement Attaching Options | P | 310,191,235 | 294,895,689 95.07% | 13,515,836 4.36% | 762,554 | 1,779,710 0.57% | 298,675,399 95.21% | 15,015,836 4.79% | 762,554 | Carried |
| 4 Approval to issue SPP Attaching Options | P | 613,812,137 | 599,101,316 97.60% | 12,931,111 2.11% | 276,801 | 1,779,710 0.29% | 883,839,539 98.39% | 14,431,111 1.61% | 276,801 | Carried |
